measles, mumps and rubella combined vaccine, live

BIOLOGICAL3 trials

Sponsors

Centers for Disease Control and Prevention, China, Sinovac (Dalian) Vaccine Technology Co., Ltd., Shanghai Institute Of Biological Products

Conditions

Adverse Event Following ImmunisationImmunotoxicityMeaslesMumpsRubellaVaccine

Phase 4

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

CompletedNCT03160820

Centers for Disease Control and Prevention, ChinaAdverse Event Following Immunisation, Measles, Mumps +1

Start: 2016-03-31End: 2017-02-28Updated: 2017-05-19

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

CompletedNCT04364399

Sinovac (Dalian) Vaccine Technology Co., Ltd.Mumps

Start: 2020-11-18End: 2021-04-07Updated: 2021-08-18

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

CompletedNCT05161845

Shanghai Institute Of Biological ProductsImmunotoxicity, Vaccine

Start: 2021-12-23End: 2022-10-01Updated: 2023-08-14